Related Experiment Videos
[Hepatic metastasis from advanced gallbladder carcinoma: clinicopathological study]
1Department of General Surgery, China-Japan Friendship Hospital, Beijing 100029.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|February 5, 2002
Summary
Liver metastasis from gallbladder cancer (LmGbCa) is associated with specific clinicopathological factors. Surgical management should consider these factors, including hepatectomy for high-risk cases.
Area of Science:
- Hepatobiliary surgery
- Gastrointestinal oncology
- Surgical pathology
Context:
- Gallbladder carcinoma frequently metastasizes to the liver.
- Understanding clinicopathological factors is crucial for effective management.
- Subserosal invasion is a common characteristic in studied cases.
Purpose:
- To identify clinicopathological factors associated with liver metastasis in gallbladder cancer.
- To inform surgical strategies for managing liver metastasis from gallbladder cancer.
Summary:
- Liver metastasis from gallbladder cancer (LmGbCa) occurred in 19.4% of 159 patients with subserosal invasion.
- LmGbCa cases correlated significantly with specific invasion depths (hinf(3), >ss), lymphatic invasion (ly(3)), venous invasion (v(3)), and tumor location (hep or circ).
- Surgical recommendations include hepatectomy for S4 and S5 segments when two risk factors are present; adjuvant therapy is advised for one risk factor with lymphatic invasion.
Impact:
- Provides insights into predicting and managing liver metastasis in gallbladder cancer.
- Aids surgeons in tailoring treatment based on identified risk factors.
- Contributes to improved patient outcomes through risk-stratified surgical and adjuvant therapy decisions.